From acronycine to benzo-[b]-acronycine derivatives: Potent antitumor agents;De l'acronycine aux dérivés de la benzo-[b]acronycine, puissants agents antitumoraux

Bulletin de l'Academie Nationale de Medecine

Volumn 191, Issue 1, 2007, Pages 83-93

  Koch, Michel ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Acronine; Acronine analogs and derivatives; Alkylating agents; Antineoplastic agents

Indexed keywords

ACRONINE; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; S 23906 1; S 23906-1; UNCLASSIFIED DRUG;

ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG SCREENING; HUMAN; NEOPLASM; REVIEW;

ACRONINE; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG EVALUATION, PRECLINICAL; HUMANS; MOLECULAR STRUCTURE; NEOPLASMS;

EID: 34548630614     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)33117-6     Document Type: Article

References (21)

1. HUGHES G.K., LAHEY F.N., PRICE J.A. -Alkaloids of the Australian Rutaceae. Nature, 1948, 162, 223-224.
2. MAC DONALD P.L., ROBERTSON A.V. -The structure of acronycine. Aust. J. Chem., 1966, 19, 275-281.
3. SVOBODA G.H. -Alkaloids of Achronychia baueri (Bauerella australiana) -II. Extraction of the alkaloids and studies of structure activity relationships. Lloydia, 1966, 29, 206-224.
4. SVOBODA G.H., POORE G.A., SIMPSON P.J., BODER G.B. -Alkaloids of Achronycia baueri. Isolation of the alkaloids and study of the antitumor and other biological properties of acronycine. J. Pharm. Sci, 1966, 55, 756-768.
5. SVOBODA G.H., NEUSS N., GORMAN M. -Alkaloids of Vinca rosea (Catharanthus roseus) - V. Preparation and characterization of alkaloids. J. Am. Pharm. Assoc Sci. Ed. 1959, 48, 659-666.
6. DORR R.T., LIDDIL J.D. -Development of a parenteral formulation of the antitumor agent acronycine. J. Drug. Dev., 1988, 1, 31-39.
7. SCARFFE J.H., BEAUMONT A.R., CROWTHER D. -Phase I-II evaluation of acronycine in patients with multiple myeloma. Cancer Treat. Rep., 1983, 67, 93-94.
8. DUNN B.P., GOUT P.W., BEER C.T. -Effects of the antineoplastic alkaloid acronycineon nucleoside uptake and incorporation into nucleic acids by cultured L5178Y cells. Cancer Res., 1973, 55, 2310-2319.
9. REDDY S.B., LINDEN W.A., ZYWIETZ F., BAISCH H., STRUCK U. -Effects of acronycine, bleomycine and cytosine arabinoside on the cell cycle. Arzneim. Forsch., 1977, 27, 1549-1553.
10. DORR R.T., LIDDIL J.D., VON HOFF D.D., SOBLE M., OSBORNE C.K. -Antitumor activity and murine pharmacokinetics of parenteral acronycine. Cancer Res., 1989, 49, 340-344.
11. MICHEL S., TILLEQUIN F., SÉGUIN E. -Structure-activity relationships in the acronycine series. Curr. Med Chem., 2002, 9, 1241-1253.
12. SCHNEIDER J., EVANS E.L., GRUNBERG E., IAN FRYER R. -Synthesis and biological activity of acronycine analogs. J. Med Chem., 1972, 15, 266-270.
13. BRUM-BOUSQUET M., MITAKU S., SKALTSOUNIS A.L., TILLEQUIN F., KOCH M. -Acronycine epoxyde : a new acridone alkaloid from several Sarcomelicope species. Planta Medica, 1988, 54, 470-471.
14. ELOMRI A., MITAKU S., MICHEL S., SKALTSOUNIS A.L., TILLEQUIN F., KOCH M., PIERRE A., GUILBAUD N., LÉONCE S., KRAUS-BERTHIER L., ROLLAND Y., ATASSI GH. -Synthesis and cytotoxic and antitumor activity of esters in the 1,2-dihydroxy-1,2-dihydroacronycine series. J. Med. Chem., 1996, 59, 4762-4766.
15. COSTES N., LE DEIT H., MICHEL S., TILLEQUIN F., KOCH M., PFEIFFER B., RENARD P., LÉONCE S., GUILBAUD N., KRAUS-BERTHIER L., PIERRE A., ATASSI GH. -Synthesis and cytotoxic and antitumor activity of benzo-[b]-pyrano[3,2-h] acridine-7-one analogues of acronycine. J. Med Chem., 2000, 43, 2395-2402.
16. GUILBAUD N., LÉONCE S., TILLEQUIN F., KOCH M., HICKMAN J., PIERRE A. -ACRONYCINE DERIVATIVES AS PROMISING ANTITUMOR AGENTS. Anticancer drugs, 2002, 13, 445-449.
17. GUILBAUD N., KRAUS-BERTHIER L., MEYER-LOSIC F., MALIVET V., CHACUN C., JAN M., TILLEQUIN F., MICHEL S., KOCH M., PFEIFFER B., ATASSI GH., HICKMAN J., PIERRE A. Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human solid tumors. Clin. Cancer Res., 2001, 7, 2573-2580.
18. DAVID-CORDONNIER M.H., LANSIAUX A., KOUACH M., BRIAND G., PIERRE A., HICKMAN J.A., BAILLY C. -Alkylation of guanine in DNA by S 23906-la novel potent antitumor compound derived from the plant alkaloid acronycine. Biochemistry, 2002, 41, 9911-9920.
19. DOAN THI MAI H., GASLONDE T., MICHEL S., TILLEQUIN F., KOCH M., BONGUI J.-B., ELOMRI A., SEGUIN E., PFEIFFER B., RENARD P., DAVID-CORDONNIER M.-H., LAINE W., BAILLY C., KRAUD-BERTHIER L., LÉONCE S., HICKMAN J., PIERRE A. -Structure-Activity relationships and mechanism of action of antitumor benzo-[b]-pyrano[3,2-b]acridine-7-one acronycine analogues. J. Med. Chem., 2003, 46, 3072-3082.
20. CORDONNIER M.H., LAINE W., LANSIAUX A., ROSU F., COLSON P., DE PAUW E., MICHEL S., TILLEQUIN F., KOCH M., HICKMAN J., PIERRE A., BAILLY C. -Covalent binding of antitumor benzoacronycines to double stranded DNA induces helix opening and the formation of simple-stranded DNA : Unique consequences of a novel DNA-bonding mechanism. Mol. Cancer Ther, 2005, 4, 71-80.
21. LÉONCE S., PÉREZ V., LAMBEL S., PEYROULAN D., TILLEQUIN F., MICHEL S., KOCH M., ATASSI GH. HICKMAN J., PIERRE A. -Induction of cyclin E and inhibition of DNA synthesis by the novel acronycine derivative S 23906-1 precede the irreversible arrest of the tumor cells in S phase, leading to apoptosis. Mol. Pharmacol., 2001, 60, 1382-1391.